USPTO serial 90501580
ALL YOU NEED IS AIR
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- HAN, DAWN L
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ALL YOU NEED IS AIR?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Garden City, NY
Garden City, NY
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Laura J. Winston
Laura J. Winston Offit Kurman, P.A.590 Madison Ave., 6th FloorNew York, NY 10022United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations and articles, namely, cartridges sold pre-filled with gas mixtures for medical use at home or in a hospital; cartridges sold pre-filled with gases, namely, nitric oxide, for medical use; chemical preparations for medical purposes, namely, for tumors, cancer, chronic obstructive pulmonary disease, cystic fibrosis, bronchiolitis, and non-tuberculosis mycobacterium; chemical preparations for pharmaceutical purposes, namely, for tumors, cancer, chronic obstructive pulmonary disease, cystic fibrosis, bronchiolitis, and non-tuberculosis mycobacterium; drugs for medical purposes, namely, pharmaceutical preparations for tumors, cancer, chronic obstructive pulmonary disease, cystic fibrosis, bronchiolitis, and non-tuberculosis mycobacterium; medicines for human purposes for the treatment of tumors, cancer, chronic obstructive pulmonary disease, cystic fibrosis, bronchiolitis, and non-tuberculosis mycobacterium | ACTIVE | — |
| 010 | Medical apparatus and instruments, namely, therapeutic devices for delivering specifically engineered pressure and gas mixtures for medical benefit to be used at home or in a hospital; diagnostic, examination, and monitoring equipment, namely, medical apparatus and instruments for diagnosing and monitoring tumors, cancer, chronic obstructive pulmonary disease, cystic fibrosis, bronchiolitis, and non-tuberculosis mycobacterium; medical diagnostic apparatus for detecting tumors, cancer, chronic obstructive pulmonary disease, cystic fibrosis, bronchiolitis, and non-tuberculosis mycobacterium; patient medical monitors for monitoring tumors, cancer, chronic obstructive pulmonary disease, cystic fibrosis, bronchiolitis, and non-tuberculosis mycobacterium; apparatus and instruments for use in connection with the administration of gases to patients for medical and therapeutic purposes, namely, medical and therapeutic gas delivery systems in the nature of therapeutic devices for delivering specifically engineered pressure and gas mixtures for medical benefit; medical apparatus in the nature of therapeutic devices for delivering specifically engineered pressure and gas mixtures for medical benefit; medical apparatus in the nature of therapeutic devices for delivering specifically engineered pressure and gas mixtures for medical benefit delivered to patients, featuring the setting, measuring, and regulating of such mixture of medical and therapeutic gases | ACTIVE | — |
| 042 | Scientific study and research in the field of tumors, cancer, chronic obstructive pulmonary disease, cystic fibrosis, bronchiolitis, and non-tuberculosis mycobacterium; scientific research in the field of tumors, cancer, chronic obstructive pulmonary disease, cystic fibrosis, bronchiolitis, and non-tuberculosis mycobacterium; new product design for others in the field of scientific research in tumors, cancer, chronic obstructive pulmonary disease, cystic fibrosis, bronchiolitis, and non-tuberculosis mycobacterium; scientific research for medical purposes in the field of tumors, cancer, chronic obstructive pulmonary disease, cystic fibrosis, bronchiolitis, and non-tuberculosis mycobacterium; medical research services, namely conducting clinical trials for others; scientific research on the use of nitric oxide for medical purposes for the treatment of tumors, cancer, chronic obstructive pulmonary disease, cystic fibrosis, bronchiolitis, and non-tuberculosis mycobacterium; scientific research on developing pharmaceutical preparations and treatments for respiratory diseases | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Beyond Air, Inc.
- Other trademarks owned by Beyond Air, Inc.
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named ALL YOU NEED IS AIR
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 3, 2025 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Nov 3, 2025 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jul 8, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 7, 2025 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Jul 7, 2025 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Mar 11, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 10, 2025 | EXT5 | SOU EXTENSION 5 FILED | — |
| Sep 25, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 25, 2024 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Sep 25, 2024 | EXT4 | SOU EXTENSION 4 FILED | — |
| Sep 25, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 10, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 10, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jul 10, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Mar 16, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Mar 15, 2024 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Mar 15, 2024 | EXT3 | SOU EXTENSION 3 FILED | — |
| Mar 15, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 6, 2023 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Dec 6, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 6, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 6, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Dec 6, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Dec 6, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Sep 26, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 22, 2023 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Sep 22, 2023 | EXT2 | SOU EXTENSION 2 FILED | — |
| Sep 22, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 7, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 7, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 7, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 7, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 7, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 7, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 29, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Mar 27, 2023 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Mar 27, 2023 | EXT1 | SOU EXTENSION 1 FILED | — |
| Mar 27, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 27, 2022 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Aug 2, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 2, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 13, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 25, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 12, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 11, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 11, 2022 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Apr 25, 2022 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Apr 25, 2022 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 25, 2022 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 9, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 8, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 8, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 8, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 8, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 8, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 23, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| May 4, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 4, 2021 | NWAP | NEW APPLICATION ENTERED | — |